A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

NCT00251797 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Brain and Nervous System
Cancer

Interventions

DRUG: Irinotecan
DRUG: Thalidomide

Sponsor

University of New Mexico